4. Biological Therapy (Experimental Lymphoma Treatment)
Despite being a relatively new treatment, biological therapy is also a common option for patients with lymphoma. It consists of proteins composed in a lab based on a single copy of humanized antibody and it’s used to stop the growth and reproduction of lymphoma cells. Monoclonal antibodies (MABs) are the most common type of treatment used in patients with lymphoma and they target specific proteins on the cell surface. Rituximab (Rituxan), also known as mabthera, is usually combined with chemotherapy and radiotherapy, but there are other options such as Obinutuzumab (Gazyva), Ofatumumab (Arzerra), and Ibritumomab tiuxetan (Zevalin).
How to apply the growing understanding of the biology of lymphoma?
